When does Boston Scientific Corporation (BSX) report earnings? On Oct 28, 2026, before the open
None of its last 12 announcements carries a time on the filing, so there is no way to say which session they fell in. Each one comes from the 8-K with item 2.02 that Boston Scientific filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 65 quarters since Jul 20, 2009, and every row links to its filing.
Next announced date: Oct 28, 2026, before the open. It comes from the company through the public Nasdaq calendar, not from the SEC: it is a scheduled date and companies do move it. Everything else on this page already happened, with its filing attached.
The last 20 quarters, one by one
"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For Boston Scientific, a median of 7 sessions over the last 12 quarters.
| Announcement | Day | Time (NY) | Session | Quarter ended | SEC report | Lead | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Wednesday | no time on the filing | Jun 30, 2026 | 10-Q · Aug 3, 2026 | 3 sessions | 8-K | |
| Apr 22, 2026 | Wednesday | no time on the filing | Mar 31, 2026 | 10-Q · May 1, 2026 | 7 sessions | 8-K | |
| Feb 4, 2026 | Wednesday | no time on the filing | Dec 31, 2025 | 10-K · Feb 17, 2026 | 8 sessions | 8-K | |
| Oct 22, 2025 | Wednesday | no time on the filing | Sep 30, 2025 | 10-Q · Nov 3, 2025 | 8 sessions | 8-K | |
| Jul 23, 2025 | Wednesday | no time on the filing | Jun 30, 2025 | 10-Q · Aug 1, 2025 | 7 sessions | 8-K | |
| Apr 23, 2025 | Wednesday | no time on the filing | Mar 31, 2025 | 10-Q · May 1, 2025 | 6 sessions | 8-K | |
| Feb 5, 2025 | Wednesday | no time on the filing | Dec 31, 2024 | 10-K · Feb 18, 2025 | 8 sessions | 8-K | |
| Oct 23, 2024 | Wednesday | no time on the filing | Sep 30, 2024 | 10-Q · Nov 1, 2024 | 7 sessions | 8-K | |
| Jul 24, 2024 | Wednesday | no time on the filing | Jun 30, 2024 | 10-Q · Aug 1, 2024 | 6 sessions | 8-K | |
| Apr 24, 2024 | Wednesday | no time on the filing | Mar 31, 2024 | 10-Q · May 1, 2024 | 5 sessions | 8-K | |
| Jan 31, 2024 | Wednesday | no time on the filing | Dec 31, 2023 | 10-K · Feb 20, 2024 | 13 sessions | 8-K | |
| Oct 26, 2023 | Thursday | no time on the filing | Sep 30, 2023 | 10-Q · Nov 1, 2023 | 4 sessions | 8-K | |
| Jul 27, 2023 | Thursday | no time on the filing | Jun 30, 2023 | 10-Q · Aug 3, 2023 | 5 sessions | 8-K | |
| Apr 26, 2023 | Wednesday | no time on the filing | Mar 31, 2023 | 10-Q · May 4, 2023 | 6 sessions | 8-K | |
| Feb 1, 2023 | Wednesday | no time on the filing | Dec 31, 2022 | 10-K · Feb 23, 2023 | 15 sessions | 8-K | |
| Oct 26, 2022 | Wednesday | no time on the filing | Sep 30, 2022 | 10-Q · Nov 3, 2022 | 6 sessions | 8-K | |
| Jul 27, 2022 | Wednesday | no time on the filing | Jun 30, 2022 | 10-Q · Aug 4, 2022 | 6 sessions | 8-K | |
| Apr 27, 2022 | Wednesday | no time on the filing | Mar 31, 2022 | 10-Q · May 5, 2022 | 6 sessions | 8-K | |
| Feb 2, 2022 | Wednesday | no time on the filing | Dec 31, 2021 | 10-K · Feb 23, 2022 | 14 sessions | 8-K | |
| Oct 27, 2021 | Wednesday | no time on the filing | Sep 30, 2021 | 10-Q · Nov 4, 2021 | 6 sessions | 8-K |
The table shows the 20 most recent quarters. All 65 are in the CSV, with the same columns and one row per quarter.
Download all 65 BSX quarters as CSV → Free, no account.
How Boston Scientific shares moved on their latest earnings
Reported EPS beat the consensus estimate in 5 of the 5 quarters with an estimate.
| Announcement | Session | Window, close to close | BSX | SPY | EPS actual / expected |
|---|---|---|---|---|---|
| Jul 29, 2026 | no time on the filing | no time: unknown which close caught it | 0.86 / 0.83 (+3.9%) | ||
| Apr 22, 2026 | no time on the filing | no time: unknown which close caught it | 0.8 / 0.79 (+1.6%) | ||
| Feb 4, 2026 | no time on the filing | no time: unknown which close caught it | 0.8 / 0.78 (+2.4%) | ||
| Oct 22, 2025 | no time on the filing | no time: unknown which close caught it | 0.75 / 0.71 (+5.1%) | ||
| Jul 23, 2025 | no time on the filing | no time: unknown which close caught it | 0.75 / 0.73 (+3.4%) | ||
| Apr 23, 2025 | no time on the filing | no time: unknown which close caught it | |||
| Feb 5, 2025 | no time on the filing | no time: unknown which close caught it | |||
| Oct 23, 2024 | no time on the filing | no time: unknown which close caught it |
Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.
Where each number comes from
From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that Boston Scientific filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. No time is published for this company: its EDGAR acceptance stamp and the official header of its filings disagree, so there is no way to know whether the stamp is in New York time or UTC, and the two readings are four or five hours apart —enough to change session—. The dates are firm; the time and the session are deliberately left empty rather than filled in with a guess. In 3 of this company's 65 quarters the date comes from the EDGAR acceptance day rather than the 8-K cover box, and those are flagged with an asterisk in the table.
What this data does not know
- The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so any 8-K time is an upper bound. The session says which one the news landed in, not what minute it was said.
- Nothing before Jul 20, 2009: it is Boston Scientific's oldest quarter with announcement and report paired in the file.
- What will happen. The page's only future date, Oct 28, 2026, was announced by Boston Scientific on the Nasdaq calendar and can be moved.
- Boston Scientific's identity is its SEC CIK (0000885725), not its symbol: symbols get recycled and renamed.
When other Healthcare companies report earnings
- MRNA
- LLY
- INCY
- CAH
- ELV
- SOLV
- BMY
- DXCM
- CVS
- HSIC
- VTRS
- JNJ
- DVA
- UHS
- CI
- BIIB
- VRTX
- REGN
- CNC
- MRK
- EW
- HUM
- MCK
- COR
- AMGN
- WAT
- WST
- TECH
- ABBV
- IDXX
- DGX
- RVTY
- MTD
- A
- ZBH
- ISRG
- TMO
- ALGN
- HCA
- UNH
- COO
- BDX
- VEEV
- MDT
- DHR
- PFE
- LH
- RMD
- IQV
- GEHC
- STE
- PODD
- SYK
- BAX
- CRL
- ZTS
- ABT
- GILD
- AJG
- DLR
More on Boston Scientific
Boston Scientific is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 395 of 464, and 49 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.
Boston Scientific (BSX) analysis page →
All ~500 S&P 500 companies, sorted by when they report →
Guide: 10-K, 10-Q and 8-K · all guides
What is behind these dates
The concepts on this page, explained from scratch in the Academy. Free, no account.
- Guessing next quarter's earnings gives no edgeWhy knowing a quarter's earnings in advance is not enough to make money: what moves the price is the gap against what was expected.
- Supply, demand and price: why it rises and falls constantlyWhat happens to the price on announcement day, and why excellent results can leave the stock falling.
- The three financial statements of a companyWhat is inside the 10-Q and the 10-K whose lag behind the announcement this page measures.
- Point-in-time data and look-ahead biasWhy the date a figure became public matters as much as the figure, which is exactly the distinction behind the two date columns above.
Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Jul 29, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.